Matches in Wikidata for { <http://www.wikidata.org/entity/Q85223947> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q85223947 description "article scientifique publié en 2014" @default.
- Q85223947 description "artículu científicu espublizáu en xunu de 2014" @default.
- Q85223947 description "scientific article published on 25 June 2014" @default.
- Q85223947 description "wetenschappelijk artikel" @default.
- Q85223947 description "наукова стаття, опублікована в червні 2014" @default.
- Q85223947 name "COST-effectiveness of salmeterol/fluticasone propionate combination (Advair(®)) in uncontrolled asthma in Canada" @default.
- Q85223947 name "COST-effectiveness of salmeterol/fluticasone propionate combination (Advair(®)) in uncontrolled asthma in Canada" @default.
- Q85223947 type Item @default.
- Q85223947 label "COST-effectiveness of salmeterol/fluticasone propionate combination (Advair(®)) in uncontrolled asthma in Canada" @default.
- Q85223947 label "COST-effectiveness of salmeterol/fluticasone propionate combination (Advair(®)) in uncontrolled asthma in Canada" @default.
- Q85223947 prefLabel "COST-effectiveness of salmeterol/fluticasone propionate combination (Advair(®)) in uncontrolled asthma in Canada" @default.
- Q85223947 prefLabel "COST-effectiveness of salmeterol/fluticasone propionate combination (Advair(®)) in uncontrolled asthma in Canada" @default.
- Q85223947 P1433 Q85223947-CE3079FB-3F77-4E87-9C14-245F0D63B8A5 @default.
- Q85223947 P1476 Q85223947-B7794048-AC61-41F7-B169-89C84ABF3390 @default.
- Q85223947 P2093 Q85223947-52D26C3E-0336-450C-B278-0DECCDCD6C7A @default.
- Q85223947 P2093 Q85223947-8CA26ED2-16A1-458B-9E72-3B7F8680E1D7 @default.
- Q85223947 P2093 Q85223947-9248421F-57FA-48C9-99D4-183C95B1B5D6 @default.
- Q85223947 P2093 Q85223947-AB81CB1B-11EB-4527-A3A7-BEA75B65DE5C @default.
- Q85223947 P2093 Q85223947-B8ABC09D-F081-4404-A56B-C2F1CC5A0145 @default.
- Q85223947 P2093 Q85223947-BEB60140-9377-4948-9764-A4B1049F3351 @default.
- Q85223947 P2093 Q85223947-C92F3F17-2FC5-4D9B-910C-1E50C3FAA9EF @default.
- Q85223947 P304 Q85223947-5C80BF8B-1F3D-4B02-B5E3-3A3779DBA5C8 @default.
- Q85223947 P31 Q85223947-56B4A250-8E91-48AA-97D0-CA655A0E5142 @default.
- Q85223947 P31 Q85223947-add640f6-a56d-40cf-be0b-d244540b764d @default.
- Q85223947 P356 Q85223947-1C617F1E-3255-44C4-887E-28181993019C @default.
- Q85223947 P433 Q85223947-72779708-055C-4ABE-A1D7-E173B7CFB76D @default.
- Q85223947 P478 Q85223947-0DAFDFD4-2DF0-4B41-90DE-6B09106DF15F @default.
- Q85223947 P577 Q85223947-1120C178-E671-45C1-9371-985AC8227D80 @default.
- Q85223947 P698 Q85223947-58F553C4-DB85-4751-8986-76CCB1FEBA16 @default.
- Q85223947 P921 Q85223947-58409F8A-6971-4BD9-8176-44FF6200E50A @default.
- Q85223947 P921 Q85223947-5F00337D-3FE4-4762-A7A6-449E6CDF47DD @default.
- Q85223947 P356 J.RMED.2014.06.005 @default.
- Q85223947 P698 25175480 @default.
- Q85223947 P1433 Q2659932 @default.
- Q85223947 P1476 "COST-effectiveness of salmeterol/fluticasone propionate combination (Advair(®)) in uncontrolled asthma in Canada" @default.
- Q85223947 P2093 "Afisi S Ismaila" @default.
- Q85223947 P2093 "Chunmei Li" @default.
- Q85223947 P2093 "Diane Corriveau" @default.
- Q85223947 P2093 "J Mark FitzGerald" @default.
- Q85223947 P2093 "Nancy Risebrough" @default.
- Q85223947 P2093 "Neil Hawkins" @default.
- Q85223947 P2093 "Zhen Su" @default.
- Q85223947 P304 "1292-1302" @default.
- Q85223947 P31 Q13442814 @default.
- Q85223947 P31 Q815382 @default.
- Q85223947 P356 "10.1016/J.RMED.2014.06.005" @default.
- Q85223947 P433 "9" @default.
- Q85223947 P478 "108" @default.
- Q85223947 P577 "2014-06-25T00:00:00Z" @default.
- Q85223947 P698 "25175480" @default.
- Q85223947 P921 Q16 @default.
- Q85223947 P921 Q35869 @default.